Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats

Sitagliptin, a dipeptidyl peptidase-4 inhibitor, has been reported to promote cardioprotection in diabetic hearts by limiting hyperglycemia and hyperlipidemia. However, little is known about the involvement of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway modul...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Drug Des Devel Ther
Hoofdauteurs: Al-Rasheed, Nouf M, Al-Rasheed, Nawal M, Hasan, Iman H, Al-Amin, Maha A, Al-Ajmi, Hanaa N, Mahmoud, Ayman M
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2016
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4933570/
https://ncbi.nlm.nih.gov/pubmed/27418808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S109287
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items